These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1915595)

  • 1. Benextramine irreversibly inhibits [125I]neuropeptide Y affinity labeling of the Y2 binding protein in bovine hippocampus.
    Li W; MacDonald RG; Hexum TD
    Eur J Pharmacol; 1991 May; 207(1):89-91. PubMed ID: 1915595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sulfhydryl groups in Y2 neuropeptide Y receptor binding activity.
    Li W; MacDonald RG; Hexum TD
    J Biol Chem; 1992 Apr; 267(11):7570-5. PubMed ID: 1348506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y receptor in bovine hippocampus is a Y2 receptor.
    Li W; MacDonald RG; Hexum TD
    Life Sci; 1992; 50(10):695-703. PubMed ID: 1310789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine selectively enhances neuropeptide Y2 receptor binding activity.
    Li W; Hexum TD
    Biochem Biophys Res Commun; 1992 Apr; 184(1):380-6. PubMed ID: 1314592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benextramine-neuropeptide Y (NPY) binding site interactions: characterization of 3H-NPY binding site heterogeneity in rat brain.
    Doughty MB; Li K; Hu L; Chu SS; Tessel R
    Neuropeptides; 1992 Nov; 23(3):169-80. PubMed ID: 1470308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide peptidomimetic antagonists of the neuropeptide Y receptor: benextramine analogs with selectivity for the peripheral Y2 receptor.
    Chaurasia C; Misse G; Tessel R; Doughty MB
    J Med Chem; 1994 Jul; 37(14):2242-8. PubMed ID: 7913507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benextramine-neuropeptide Y receptor interactions: contribution of the benzylic moieties to [3H]neuropeptide Y displacement activity.
    Doughty MB; Chaurasia CS; Li K
    J Med Chem; 1993 Jan; 36(2):272-9. PubMed ID: 8093737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding profile of benextramine at neuropeptide Y receptor subtypes in rat brain areas.
    Melchiorre C; Romualdi P; Bolognesi ML; Donatini A; Ferri S
    Eur J Pharmacol; 1994 Nov; 265(1-2):93-8. PubMed ID: 7883034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of neuropeptide Y (NPY) receptors in human hippocampus.
    Li W; Hexum TD
    Brain Res; 1991 Jul; 553(1):167-70. PubMed ID: 1657277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of the putative neuropeptide Y antagonists, benextramine and PYX-2, to inhibit Y2 receptors in rat isolated prostatic vas deferens.
    Palea S; Corsi M; Rimland JM; Trist DG; Ratti E
    Br J Pharmacol; 1995 Nov; 116(5):2401-6. PubMed ID: 8581275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding sites for 125I-neuropeptide Y (NPY) on membranes from bovine adrenal medulla.
    Cherdchu C; Deupree JD; Hexum TD
    Eur J Pharmacol; 1989 Dec; 173(2-3):115-9. PubMed ID: 2625132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
    Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
    J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
    Palea S; Corsi M; Rimland JM; Trist DG
    Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
    Kahl U; Langel U; Bartfai T; Grundemar L
    Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of neuropeptide Y to its receptor on rat brain membranes.
    Mannon PJ; Taylor IL; Kaiser LM; Nguyen TD
    Am J Physiol; 1989 Mar; 256(3 Pt 1):G637-43. PubMed ID: 2538077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, receptor binding, and crosslinking of photoactive analogues of neuropeptide Y.
    Beck-Sickinger AG; Wieland HA; Brunner J
    J Recept Signal Transduct Res; 1995; 15(1-4):473-85. PubMed ID: 8903958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential increases of [125I]NPY1-36 binding in the hippocampal formation produced by the NPY Y2 receptor agonist NPY13-36.
    Hedlund P; Bjelke B; Aguirre JA; Fuxe K
    Acta Physiol Scand; 1991 Feb; 141(2):279-80. PubMed ID: 1646560
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J; Li W; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effects by sigma ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum.
    Hong W; Werling L
    Brain Res; 2001 May; 901(1-2):208-18. PubMed ID: 11368969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benextramine, an NPY antagonist, improves sexual behavior in male rats.
    Poggioli R; Benelli A; Arletti R; Menozzi B; Bertolini A
    Neuropeptides; 1994 May; 26(5):355-8. PubMed ID: 8065551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.